Under construction – not a live service
Sign in
Taking peopleNo phase

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Key facts

Who runs it
Peking University Third Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
15 Dec 2023
Expected to end
31 Dec 2027
Type of study
Interventional
Treatments tested
  • 18F-AlF-FAPI PET/CT, 99mTc-DTPA SPECT/CT
Record updated
11 April 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Patients diagnosed with TED
  • Complete understanding and voluntary participation in this study, with the signing of an informed consent form

Who cannot take part

  • Suffering from claustrophobia or other psychiatric disorders
  • Other conditions deemed unsuitable for participation in the trial by the investigator
  • Severe liver or kidney dysfunction
  • Inability to maintain a supine position for 5 minutes to cooperate with the examination
  • Patients planning pregnancy or in the prenatal or lactation period

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

FAPI PET has been developed as a promising approach for the evaluation of fibroinflammatory, such as in inflammatory bowel disease. This prospective study aims to explore the value of 18F-AlF-FAPI PET/CT in assessing the activity of Thyroid Eye Disease (TED) and investigate whether FAPI PET/CT may be superior to 99mTc-DTPA SPECT/CT for the diagnosis, therapy response assessment, and follow-up of TED.

The group in the trial

  • Experimental armTreatment being tested

    Patients with TED will be recruited in the study. Interventions: Diagnostic Test: 18F-AlF-FAPI PET/CT and 99mTc-DTPA SPECT/CT.

    Treatment: 18F-AlF-FAPI PET/CT, 99mTc-DTPA SPECT/CT

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Fit questions
Built from NCT06359795, who can take part
Record updated
11 April 2024